Madison-based Exact Sciences (NASDAQ: EXAS) said that Cologuard, the company’s stool-based DNA test for colorectal cancer, will be covered as an in-network service for members of the Louisville, KY-based health insurer Humana (NYSE: HUM), effective Jan. 1. Cologuard is now covered by health plans in the U.S. that together have more than 153 million members, according to a post on the stock market website Seeking Alpha. Other major insurers that have recently agreed to cover the test include TRICARE, which provides health benefits to 9.4 million current and former U.S. military personnel, and Bloomfield, CT-based Cigna (NYSE: CI), which added Cologuard to its medical coverage policy decision in October.
—Fiserv, the Brookfield-based financial services giant, said it has agreed to acquire Online Banking Solutions, an Atlanta-based developer of tools for cash management and digital business banking. Terms of the transaction, which Fiserv (NASDAQ: FISV) said is expected to close later this month, were not disclosed in a news release announcing the deal. In January, the company bought the Community Financial Services business of Naples, FL-Based ACI Worldwide (NASDAQ: ACIW) in a $200 million cash deal.